Company NeuroScientific Biopharmaceuticals Limited
Equities
NSB
AU0000012973
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.049 AUD | 0.00% | +13.95% | +11.36% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Simon Scott
CTO | Chief Tech/Sci/R&D Officer | - | 22-03-31 |
Dougal Thring
COO | Chief Operating Officer | - | 21-03-30 |
Anton Uvarov
BRD | Director/Board Member | - | 17-09-28 |
- | - | ||
Corporate Secretary | - | Feb. 05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anton Uvarov
BRD | Director/Board Member | - | 17-09-28 |
Chairman | - | Nov. 16 | |
Tony Keating
BRD | Director/Board Member | - | Dec. 04 |
Clarke Barlow
BRD | Director/Board Member | 43 | Nov. 16 |
Linda Friedland
BRD | Director/Board Member | - | 23-10-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 144,604,870 | 94,222,747 ( 65.16 %) | 0 | 65.16 % |
Company contact information
Neuroscientific Biopharmaceuticals Ltd.
85 Forrest Street Suite 5
6011, Cottesloe
+61 8 6382 1805
http://www.neuroscientific.comSector
1st Jan change | Capi. | |
---|---|---|
+11.36% | 4.7M | |
+46.02% | 54.63B | |
-6.95% | 39.92B | |
+37.07% | 38.82B | |
+12.72% | 26.86B | |
-11.17% | 26.22B | |
-22.13% | 18.78B | |
+24.91% | 12.21B | |
+0.18% | 12.16B | |
+25.20% | 11.94B |
- Stock Market
- Equities
- NSB Stock
- Company NeuroScientific Biopharmaceuticals Limited